• Please log in or register to access this feature.

Research Article

You have free access to this content

Clinical significance of genetic aberrations in secondary acute myeloid leukemia†

  1. Jelena D. Milosevic1,
  2. Ana Puda1,
  3. Luca Malcovati2,
  4. Tiina Berg1,
  5. Michael Hofbauer1,
  6. Alexey Stukalov1,
  7. Thorsten Klampfl1,
  8. Ashot S. Harutyunyan1,
  9. Heinz Gisslinger3,
  10. Bettina Gisslinger3,
  11. Tatiana Burjanivova4,
  12. Elisa Rumi2,
  13. Daniela Pietra2,
  14. Chiara Elena2,
  15. Alessandro M. Vannucchi5,
  16. Michael Doubek6,7,
  17. Dana Dvorakova6,
  18. Blanka Robesova6,
  19. Rotraud Wieser8,
  20. Elisabeth Koller9,
  21. Nada Suvajdzic10,
  22. Dragica Tomin10,
  23. Natasa Tosic11,
  24. Jacques Colinge1,
  25. Zdenek Racil6,7,
  26. Michael Steurer12,
  27. Sonja Pavlovic11,
  28. Mario Cazzola2,
  29. Robert Kralovics1,3,*

Article first published online: 7 AUG 2012

DOI: 10.1002/ajh.23309

Issue

American Journal of Hematology

American Journal of Hematology

Volume 87, Issue 11, pages 1010–1016, November 2012

Additional Information

How to Cite

Milosevic, J. D., Puda, A., Malcovati, L., Berg, T., Hofbauer, M., Stukalov, A., Klampfl, T., Harutyunyan, A. S., Gisslinger, H., Gisslinger, B., Burjanivova, T., Rumi, E., Pietra, D., Elena, C., Vannucchi, A. M., Doubek, M., Dvorakova, D., Robesova, B., Wieser, R., Koller, E., Suvajdzic, N., Tomin, D., Tosic, N., Colinge, J., Racil, Z., Steurer, M., Pavlovic, S., Cazzola, M. and Kralovics, R. (2012), Clinical significance of genetic aberrations in secondary acute myeloid leukemia. Am. J. Hematol., 87: 1010–1016. doi: 10.1002/ajh.23309

Author Information

  1. 1

    CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria

  2. 2

    Department of Hematology, University of Pavia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

  3. 3

    Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University of Vienna, Vienna, Austria

  4. 4

    Department of Molecular Biology, Jessenius Faculty of Medicine, Comenius University in Martin, Martin, Slovakia

  5. 5

    Section of Hematology, University of Florence, Florence, Italy

  6. 6

    Department of Internal Medicine Hematology and Oncology, University Hospital Brno, Masaryk University Brno, Brno, Czech Republic

  7. 7

    CEITEC—Central European Institute of Technology, Masaryk University Brno, Brno, Czech Republic

  8. 8

    Clinic of Medicine I, Medical University of Vienna, Vienna, Austria

  9. 9

    Medical Department III, Center for Hematology and Oncology, Hanusch Hospital, Vienna, Austria

  10. 10

    Clinic of Hematology, Clinical Center of Serbia, University of Belgrade, School of Medicine, Belgrade, Serbia

  11. 11

    Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia

  12. 12

    Division of Hematology and Oncology, Innsbruck University Hospital, Innsbruck, Austria

*CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Lazarettgasse 14, BT25.3, A-1090 Vienna, Austria

  1. †

    Conflict of interest: The authors have no relevant conflicts of interest to disclose.

Publication History

  1. Issue published online: 23 OCT 2012
  2. Article first published online: 7 AUG 2012
  3. Accepted manuscript online: 9 JUL 2012 06:06AM EST
  4. Manuscript Received: 2 JUL 2012
  5. Manuscript Accepted: 2 JUL 2012

Funded by

  • Austrian Science Fund and the MPN Research Foundation. Grant Number: P23257-B12
  • Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano) “Special Program Molecular Clinical Oncology 5×1000″ to AGIMM (AIRC-Gruppo Italiano Malattie Mieloproliferative—available at: ) (to M.C. and A.M.V.) [http://www.progettoagimm.it]. Grant Number: 1005
  • Fondazione Cariplo
  • AIRC. Grant Number: 9034 and MIUR-20084XBENM_002
  • Italian Society of Experimental Hematology (SIES)
  • Italian Ministry of Health for young investigator
  • “Support of human resources development using the most modern methods and forms of education at JFM CU in Martin”. Grant Number: ITMS 26110230031
  • Ministry of Education and Science of Republic of Serbia (MES RS). Grant Number: Project III 41004

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (625K)

Additional Supporting Information may be found in the online version of this article.

FilenameFormatSizeDescription
AJH_23309_sm_SuppFig1.tif3042KSupporting Information Figure 1.
AJH_23309_sm_SuppFig2.tif15435KSupporting Information Figure 2.
AJH_23309_sm_SuppInfo.doc435KSupporting Information

Please note: Wiley-Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

View Full Article with Supporting Information (HTML) Get PDF (625K)